Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitation

NCT05774808 is registered in ClinicalTrials.gov with Michele De Bonis as lead sponsor.

NCT NCT05774808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05774808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fate of Moderate Secondary Mitral Regurgitation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Regurgitation
Lead sponsor
Michele De Bonis
Phase
Observational
Overall status
Completed
Start date
February 2, 2022
Completion date
February 23, 2022
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, functional mitral regurgitation